DNA methylation as a therapeutic target in hematologic disorders: recent results in older patients with myelodysplasia and acute myeloid leukemia

B Rüter, PW Wijermans, M Lübbert - International journal of hematology, 2004 - Springer
DNA methylation provides a major epigenetic code (besides histone modification) of the
lineage-and developmentspecific genes (such as regulators of differentiation in the …

DNA methylation changes in hematologic malignancies: biologic and clinical implications.

JPJ Issa, SB Baylin, JG Herman - Leukemia (08876924), 1997 - search.ebscohost.com
DNA methylation changes are among the most common detectable abnormalities in human
neoplasia. Hypermethylation within the promoters of selected genes appears to be …

Inhibitors of DNA methylation in the treatment of hematological malignancies and MDS

G Leone, MT Voso, L Teofili, M Lübbert - Clinical Immunology, 2003 - Elsevier
DNA methylation abnormalities have recently emerged as one of the most frequent
molecular changes in hematopoietic neoplasms. Since methylation and transcriptional …

The DNA methylation landscape of hematological malignancies: an update

P Blecua, L Martinez‐Verbo, M Esteller - Molecular Oncology, 2020 - Wiley Online Library
The rapid advances in high‐throughput sequencing technologies have made it more evident
that epigenetic modifications orchestrate a plethora of complex biological processes. During …

[HTML][HTML] Role of epigenetic changes in hematological malignancies

U Lehmann, K Brakensiek, H Kreipe - Annals of hematology, 2004 - Springer
Inactivation of tumor suppressor genes is an important event contributing to the development
of neoplasia. In addition to the classic genetic mechanisms of deletion or inactivating point …

DNA methylation in normal and malignant hematopoiesis

H Celik, A Kramer, GA Challen - International journal of hematology, 2016 - Springer
The study of DNA methylation has been a rapidly expanding field since its dawn in the
1960s. DNA methylation is an epigenetic modification that plays a crucial role in guiding the …

DNA methylation as a therapeutic target in cancer

JPJ Issa - Clinical Cancer Research, 2007 - AACR
Targeting DNA methylation for cancer therapy has had a rocky history. The first reports on
DNA methylation changes in cancer described global loss of methylation, which has been …

Hypomethylating agents in the treatment of myelodysplastic syndromes and myeloid leukemia

A Szmigielska-Kaplon, T Robak - Current Cancer Drug Targets, 2011 - ingentaconnect.com
Epigenetic changes play an important role in cancer pathogenesis. Hypermethylation of
DNA generally results in decreased expression of tumor suppressor genes and defective …

Clinical development of demethylating agents in hematology

SC Navada, J Steinmann, M Lübbert… - The Journal of …, 2014 - Am Soc Clin Investig
The term epigenetics refers to the heritable changes in gene expression that are not
associated with a change in the actual DNA sequence. Epigenetic dysregulation is linked to …

MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation

ME Figueroa, L Skrabanek, Y Li… - Blood, The Journal …, 2009 - ashpublications.org
Increasing evidence shows aberrant hypermethylation of genes occurring in and potentially
contributing to pathogenesis of myeloid malignancies. Several of these diseases, such as …